POS-255 EFFECT OF DAPAGLIFLOZIN ON BLOOD PRESSURE IN PATIENTS WITH CKD: A PRE-SPECIFIED ANALYSIS FROM DAPA-CKD

Autor: Provenzano, M., Toto, R.D., Vart, P., Umanath, K., Luis Górriz, J., Mark, P.B., Mann, J.F.E., Chertow, G.M., McMurray, J.J.V., Correa-Rotter, R., Rossing, P., Langkilde, A.M., Stefánsson, B.V., Wheeler, D.C., Lambers Heerspink, H.
Zdroj: In Kidney International Reports February 2022 7(2) Supplement:S112-S112
Databáze: ScienceDirect